Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2015 FY- Text added to 2016 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
abandonment, Actemra, alleviate, amelioration, Amgen, ANA, andin, anti, antinuclear, APA, approximetaly, artificial, azathioprine, bid, Biogen, Bulletin, cevilemine, cevimeline, cholinergic, classic, cyclosporine, dry, ECL, Evoxac, exocrine, extraglandular, female, Fopundation, fromin, FVOCI, gastrointestinal, gland, glandular, HCW, hundred, hydroxychloroquine, Hypergammaglobulinemia, Immunomodulary, immunomodulatory, incubated, incubation, infiltration, interstitial, isolated, Kingdom, lacrimal, liver, lung, lymphocytic, mofetil, mononuclear, mouth, mRNA, myalgia, mycophenolate, neurologic, ocular, OTC, OTCQX, ourADSscould, page, parotid, penny, pilocarpine, precentage, presence, provisional, pSS, pulmonary, quotation, recieved, regained, relief, Renshaw, RF, Rituxan, rituximab, Roche, Rodman, RSLV, Salagen, salivary, sicca, Sjogren, SPA, SS, SSA, SSB, stimulation, Strasbourg, suitable, symptomatic, symptomatically, syndrome, thourgh, undertaken, unsolicited, usage, vasculitic, volatilityand, Wainwright, Wehave, xerophthalmia, xerostomia
Removed:
accumulation, acute, African, allogeneic, begun, binding, bleeding, blended, bone, bortezomib, bringing, broadly, buyer, capitalized, carfilzomib, channel, chemotherapy, clonal, cloning, collecting, combined, compartment, computed, conclusion, conferred, constructive, continuance, culture, cumulatively, decade, Delaware, depending, derecognized, devastating, deviation, differentiation, disabled, dispersion, distributor, domiciled, doubtful, enacted, encourage, Enterprise, erythroid, Erythropoetin, examined, experimental, extend, finite, forfeiture, fulltime, glycoprotein, gradual, gradually, haematopoietic, hormone, immunologically, intragroup, IRB, Knesset, led, lenalidomide, lineage, lived, location, malignancy, mammalian, managerial, marrow, master, men, merchandise, nausea, observation, partly, pathological, periodically, phased, plant, point, pomalidomide, Pomalyst, poor, progenitor, prognostic, progressive, proliferation, promoting, receptor, reclassified, recurrent, red, regulator, reissued, relapsed, remission, revlimid, seller, selling, settle, sheet, Society, solid, sourced, stem, substantively, supplementary, surface, susceptibility, systematically, today, transplantation, twenty, uncollectible, updated, upkeep, Velcade, viability, vital, vomiting, warranty
Valuein 2015 FY filing- Value in 2016 FY filing
Original filings
Filing view